EirGenix is a Taiwan-based biopharmaceutical CDMO specializing in cell line development, process development, and commercial-scale production of biologics including biosimilars. The company operates facilities in Xizhi and Zhubei, Taiwan, with the Zhubei plant dedicated to late-stage development and commercial production of biological products. EirGenix provides comprehensive services from DNA replication through stable cell line generation to clinical and commercial manufacturing.
biosimilar development, cell line development, biologics manufacturing, process development
1 site worldwide
No reviews available yet.
No documents available.